Inner Mongolia targets RMB 100B biomanufacturing output by 2030

Regional industrial policy is becoming a structural driver for biomanufacturing capacity in China, and Inner Mongolia's plan signals that competition for biotech investment is spreading beyond established coastal clusters. The emphasis on building the full industrial chain, rather than isolated production, matters for upstream suppliers of feedstocks, equipment and fermentation capacity. Whether the enterprise-count and output targets translate into actual capacity, and how much of it serves export versus domestic demand, is the open question.